Endothelial Progenitor Cells and Their Role in Multiple Myeloma
Author Information
Author(s): Marc Braunstein, Tayfun Özçelik, Sevgi Bağışlar, Varsha Vakil, Eric L. P. Smith, Kezhi Dai, Cemaliye B. Akyerli, Olcay A. Batuman
Primary Institution: State University of New York Downstate Medical Center
Hypothesis
Do endothelial progenitor cells (EPCs) in multiple myeloma display clonal restriction?
Conclusion
EPCs in a significant number of multiple myeloma patients are genetically linked to tumor cells, suggesting a mechanism for increased tumor blood vessel formation.
Supporting Evidence
- 64% of patients showed significant skewing in X-chromosome inactivation patterns in EPCs.
- 71% of patients had identical immunoglobulin heavy-chain gene rearrangement in EPCs and bone marrow cells.
- Advanced age correlated with poorer clinical status in patients with skewed XCI in EPCs.
Takeaway
In some patients with multiple myeloma, the cells that help make new blood vessels are actually related to the cancer cells, which might help the cancer grow.
Methodology
The study involved analyzing X-chromosome inactivation patterns and immunoglobulin heavy-chain gene rearrangement in EPCs from female multiple myeloma patients.
Potential Biases
Potential bias due to the small number of patients and the specific population studied.
Limitations
The study was limited by the small sample size and the inability to obtain hair root control DNA for XCI studies in some patients.
Participant Demographics
Twenty-three female patients with multiple myeloma, aged 50 to 73.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website